About Stan Rose
Form D filings for Xeno Biosciences from 2021 to 2023 list Stan Rose as director.
Stan Rose first appears on SEC filings in 2021.
Experience
This experience comes from SEC filings. The years are when the filings name Stan Rose in the role, so the role may have started earlier or lasted longer.
Key Colleagues at Startups
The people Stan Rose works with at each company, as listed on that company's latest Form D.
Xeno Biosciences Inc. · Form D, Jan 5, 2023
DB
David Beno
Chief Executive Officer and director
JA
Jeffrey Arnold
Director
MK
Michael Koeris
Director
TH
Tom Hughes
Director